引用本文： 王海燕. 循證醫(yī)學(xué)在我國腎臟病學(xué)科發(fā)展中的應(yīng)用現(xiàn)狀與展望. 中國循證醫(yī)學(xué)雜志, 2006, 06(7): 471-473. doi: 復(fù)制
| 1. | Hou FF, Zhang X, Zhang GH, et al. Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency. N England J Med, 2006; 354(2): 131-140. |
| 2. | TG Cui, FF Hou, XM Chen, et al. A Multi-Center Controlted Clinical Trial of Leplunomide Treating Proliferative Lupus Nephritis. J Am Soc Nephrol, 2004; 15:53A. |
| 3. | Chen X, Qiu Q, Tang L, et al. Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant, 2004; 19(4): 852-857. |
| 4. | Gu Y, Ding F, Chen N, et al. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Ren Fail, 2005; 27(2): 205-212. |
| 5. | Ying-Chun Ma, Li Zuo, Jiang-Hua CHEN，et al. Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease. J Am Soc Nephrol. 2006. in press. |
| 6. | Gang Xin, Mei Wang, Li-li Jiao, et al. Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria. Clinica Chimica Acta, 2004;350:35-39. |
| 7. | Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in Nephrology. J Am Soc Nephrol, 2004;15(2): 411-419. |
| 8. | Flanc RS, Roberts MA, Strippoli GF, et al. Treatment of Diffuse Proliferative Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials. Am J Kidney Dis, 2004; 43(2): 197-208. |
| 9. | Juon P Casas, Weiliang Chua, Stavros Laukogeongakis, et al. Effect of inhibitors of the rennin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet, 2005; 366(10): 2026~33. |
| 10. | Martinson BC, Anderson MS, de Vries R. Scientists behaving badly. Nature, 2005; 435(7043): 737-738. |
- 1. Hou FF, Zhang X, Zhang GH, et al. Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency. N England J Med, 2006; 354(2): 131-140.
- 2. TG Cui, FF Hou, XM Chen, et al. A Multi-Center Controlted Clinical Trial of Leplunomide Treating Proliferative Lupus Nephritis. J Am Soc Nephrol, 2004; 15:53A.
- 3. Chen X, Qiu Q, Tang L, et al. Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant, 2004; 19(4): 852-857.
- 4. Gu Y, Ding F, Chen N, et al. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Ren Fail, 2005; 27(2): 205-212.
- 5. Ying-Chun Ma, Li Zuo, Jiang-Hua CHEN，et al. Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease. J Am Soc Nephrol. 2006. in press.
- 6. Gang Xin, Mei Wang, Li-li Jiao, et al. Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria. Clinica Chimica Acta, 2004;350:35-39.
- 7. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in Nephrology. J Am Soc Nephrol, 2004;15(2): 411-419.
- 8. Flanc RS, Roberts MA, Strippoli GF, et al. Treatment of Diffuse Proliferative Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials. Am J Kidney Dis, 2004; 43(2): 197-208.
- 9. Juon P Casas, Weiliang Chua, Stavros Laukogeongakis, et al. Effect of inhibitors of the rennin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet, 2005; 366(10): 2026~33.
- 10. Martinson BC, Anderson MS, de Vries R. Scientists behaving badly. Nature, 2005; 435(7043): 737-738.